By Jeannie O'Sullivan ( May 10, 2018, 10:05 PM EDT) -- The New Jersey Supreme Court has agreed to give multicounty litigation designation to lawsuits against Bristol-Myers Squibb Co. and Otsuka America Pharmaceutical Inc. over certain side effects relating to the antipsychotic drug Abilify, according to a Wednesday notice to the bar....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.